Neuramis Volume with Lidocaine

Neuramis Volume with Lidocaine: Versatile Mid-Density HA Filler with Anesthetic for Balanced Volumization and Contouring

Neuramis Volume with Lidocaine, manufactured by **LG Chem Life Sciences**, is a **medium-density, monophasic, non-animal stabilized hyaluronic acid (NASHA) dermal filler** featuring **integrated 0.3% lidocaine** for enhanced patient comfort. Presented in a **1.0 ml prefilled syringe**, it contains a **moderate concentration (20 mg/ml) of cross-linked HA**. Designed as a versatile “workhorse” filler, it strikes an optimal balance between elasticity and spreadability, making it ideal for **moderate volumization, contouring, and correction of medium-depth folds** in the mid-to-deep dermis and subcutaneous tissue. The integrated lidocaine significantly reduces injection discomfort.https://skin-reboot.com/

**Core Technology & Properties:**
* **Premixed Monophasic NASHA Gel:** Homogeneous, BDDE-cross-linked HA matrix ensures smooth tissue integration, predictable flow, and stability.
* **Integrated 0.3% Lidocaine HCl:** Provides rapid local anesthesia during injection, improving patient tolerance.
* **Medium-High G-Prime (Elasticity):** Offers **good lifting capacity and resistance to deformation** – more substantial than Neuramis Light/Super but less rigid than Neuramis Deep. Provides natural projection without excessive hardness.
* **Medium Cohesivity:** Particles bind cohesively enough for structural integrity and minimized migration, yet fluid enough for smooth tissue layering and distribution.
* **Balanced Viscosity:** Facilitates injection through needles or cannulas and allows for both bolus placement and linear threading techniques depending on the indication and layer.
* **Optimized Particle Size:** Engineered for durability and performance in the mid-dermis to subcutaneous layers.

**Mechanism of Action:**
1. **Volumization & Contouring:** Gel restores lost volume and enhances facial contours upon injection.
2. **Fold Correction:** Physically fills and softens moderate-depth nasolabial folds, marionette lines, and labiomental folds.
3. **Hydration:** HA binds water, improving tissue hydration.
4. **Biostimulation:** Stimulates gradual collagen production for sustained improvement.
5. **Anesthesia:** Lidocaine blocks local nerve signals, reducing procedural pain.

**Primary Indications:**
* **Cheek Augmentation & Volumization:** Restoring midface volume and contour (often used in the subcutaneous/SMAS layer).
* **Moderate Nasolabial Folds (NLFs) & Marionette Lines:** Correcting folds requiring both volume and lift.
* **Pre-jowl Sulcus & Jawline Definition:** Enhancing mandibular contour and smoothing the pre-jowl area.
* **Lip Augmentation (Body):** Adding volume and structure to the lip body (injection technique critical).
* **Chin Augmentation (Moderate):** Enhancing chin projection.
* **Temporal Hollowing (Moderate):** Restoring volume to the temples.
* **Dorsal Hand Rejuvenation:** Correcting volume loss and prominent tendons/veins on the back of the hands.

**Key Administration Considerations:**
* **Ready-to-Use:** No reconstitution required. Prime syringe carefully.
* **Anesthesia:** Integrated lidocaine provides core comfort; adjunctive topical numbing cream may be used for sensitive areas/lips.
* **Technique:** Highly versatile – suitable for **bolus, fanning, linear threading, and cross-hatching**:
* **Needles:** Sharp needles (e.g., 25-27G) for precise placement.
* **Cannulas:** Highly compatible with blunt microcannulas (e.g., 22-25G, 25-50mm) for safer placement in vascular areas (lips, NLFs) and smoother layering.
* **Depth:** **Mid to deep dermis or subcutaneous tissue.** Avoid superficial dermis to prevent Tyndall effect or visibility.
* **Volume:** Moderate volumes per point or area. Gradual build-up recommended for natural results.
* **Post-Treatment:** Expect swelling, redness, tenderness, and potential bruising. Avoid pressure/massage on treated areas.
* **Longevity:** Results typically last **9-12 months**, reflecting its balanced HA concentration and cross-linking.
* **Safety:** Standard filler risks. **Critical Risks:** **Vascular occlusion** (especially in lips/NLF area), requiring expert anatomy knowledge, aspiration, and cannula preference. **Tyndall effect** if injected too superficially. Risk of visible nodules if overcorrected or technique poor. Lidocaine allergy screening essential.
* **Regulatory Status:** **CE marked** (Europe/international). **Not FDA-approved in the USA.**
* **Prescription:** Prescription medical device.

Neuramis Volume with Lidocaine offers practitioners a comfortable, adaptable solution for achieving natural-looking volume restoration and contouring across multiple facial and hand indications, leveraging a balanced monophasic HA gel with integrated anesthetic.CONTACT US